Insider Trading March 18, 2026

Gaia Director Buys $17,061 of Class A Shares as Stock Sits Near 52-Week Low

Director Paul Howard Sutherland adds 5,486 shares; company posts mixed Q4 2025 results with slight EPS beat but revenue shortfall

By Jordan Park GAIA
Gaia Director Buys $17,061 of Class A Shares as Stock Sits Near 52-Week Low
GAIA

Paul Howard Sutherland, a director at Gaia, Inc., purchased 5,486 shares of Class A common stock on March 16, 2026, paying $3.11 per share for a total of $17,061. The transaction leaves Sutherland with 302,943 shares directly owned. The buy occurred while Gaia shares traded near a 52-week low of $2.93 and after a six-month decline of 49%. Separately, Gaia reported fourth-quarter 2025 results with an EPS of -$0.02 versus an expected -$0.03 and revenue of $25.5 million versus an anticipated $25.85 million; the release produced little movement in after-hours trading and no immediate analyst rating changes were reported.

Key Points

  • Director Paul Howard Sutherland purchased 5,486 Class A shares on March 16, 2026, at $3.11 per share totaling $17,061.
  • Following the trade, Sutherland directly owns 302,943 shares of Gaia, Inc.; the stock has declined roughly 49% over six months and was trading near a 52-week low of $2.93.
  • Gaia’s Q4 2025 results showed an EPS of -$0.02 (better than the -$0.03 expectation) and revenue of $25.5 million (below the $25.85 million forecast); the release had little impact on after-hours trading and no immediate analyst rating changes were reported.

Paul Howard Sutherland, a member of the board of directors at Gaia, Inc. (NASDAQ:GAIA), executed a purchase of 5,486 shares of the company’s Class A common stock on March 16, 2026. The filing shows the shares were acquired at $3.11 apiece, bringing the total consideration for the transaction to $17,061.

After the acquisition, Sutherland is recorded as directly holding 302,943 shares of Gaia, Inc. The purchase coincided with the stock trading close to its 52-week low of $2.93. The company’s share price has fallen about 49% over the preceding six months.

According to an InvestingPro analysis cited in the filing, the stock appears undervalued at its current levels. The filing notes that a Pro Research Report covering GAIA is available alongside reports for more than 1,400 other U.S. equities for those with access to that platform.

Separately, Gaia Inc. released fourth-quarter 2025 financial results. The company reported an earnings per share (EPS) of -$0.02, which was marginally better than the consensus expectation of -$0.03. Revenue for the quarter came in at $25.5 million, below the $25.85 million forecast.

The earnings announcement did not generate a significant move in the stock’s after-hours trading session, and analyst firms had not issued upgrades or downgrades in the immediate period following the release, according to the reporting. The company’s financial trajectory and market reception remain points for investors to monitor in subsequent reports.


Context and limitations

The transaction is recorded as a straightforward director purchase; the filing documents the quantities, price, date, and resulting direct ownership. Beyond those facts and the published quarterly results, no additional motives, future guidance, or analyst actions were reported in connection with the transaction.

Risks

  • Revenue shortfall in Q4 2025 relative to expectations - may affect investor sentiment and is a risk for equity performance (impacts equity markets and corporate sector).
  • Share price near a 52-week low and a 49% six-month decline - continued price weakness presents market risk for current and prospective shareholders (impacts equity markets and investor portfolios).
  • Limited analyst response following the earnings release - lack of immediate brokerage guidance may reduce near-term clarity for investors (impacts market coverage and investor decision-making).

More from Insider Trading

Wesbanco Director Kerry Stemler Buys $30,800 in WSBC Stock as Bank Pursues Florida Expansion Mar 18, 2026 Ten-Percent Expensify Holder Adds $2.13 Million in Shares as Stock Trades Near 52-Week Low Mar 18, 2026 Foxx Development CEO Disposes of $30,436 in Stock; Board Addition and Meeting Clarification Also Filed Mar 18, 2026 IRadimed CEO Disposes $762,970 in Stock as Shares Trade Near Yearly Peak Mar 18, 2026 Harvard Bioscience Director Increases Stake with $48,700 Purchase Mar 18, 2026